TALARIS THERAPEUTICS INC (TALS)
US87410C1045 - Common Stock
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 18.35M | 13.67M | 18.61M | 17.60M | 39.00M | |||
| Marketable Securities | 133.90M | 167.61M | 225.36M | 131.90M | 0.00 | |||
| Receivables | N/A | N/A | N/A | 400.00K | 0.00 | |||
| Other Current Assets | 3.96M | 4.33M | 2.54M | 900.00K | 1.80M | |||
| Total Current Assets | 156.21M | 185.61M | 246.51M | 150.80M | 40.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.05M | 7.99M | 4.80M | 2.00M | 1.10M | |||
| Other Non-Current Assets | 1.86M | 111.00K | 104.00K | 0.00 | 0.00 | |||
| Total Non-Current Assets | 2.91M | 8.10M | 4.91M | 2.00M | 1.10M | |||
| TOTAL ASSETS | 159.12M | 193.72M | 251.42M | 152.80M | 41.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 6.95M | 7.58M | 5.43M | 2.10M | 1.30M | |||
| Accounts Payable | 2.93M | 3.89M | 2.56M | 800.00K | 700.00K | |||
| Other Current Liabilities | 250.00K | N/A | N/A | 500.00K | 300.00K | |||
| Total Current Liabilities | 10.13M | 11.46M | 7.99M | 3.40M | 2.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 555.00K | 2.20M | 626.00K | 1.40M | 100.00K | |||
| Total Non-Current Liabilities | 555.00K | 2.20M | 626.00K | 1.40M | 100.00K | |||
| TOTAL LIABILITIES | 10.69M | 13.66M | 8.61M | 4.80M | 2.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -201.98M | -164.74M | -90.85M | -43.00M | -20.30M | |||
| Additional Paid In Capital | 350.62M | 345.51M | 333.73M | 4.90M | 3.20M | |||
| Common Shares | 4.00K | 4.00K | 4.00K | 186.20M | 56.70M | |||
| Shares Outstanding | 42.55M | 41.63M | 40.91M | 41.20M | 41.20M | |||
| Tangible Book Value per Share | 3.49 | 4.33 | 5.93 | -0.93 | -0.41 | |||
| Total Shareholders' Equity | 148.43M | 180.06M | 242.81M | 148.00M | 39.60M | |||
| TOTAL LIABILITIES AND EQUITY | 159.12M | 193.72M | 251.42M | 152.80M | 41.90M | |||
| Statistics | ||||||||
| Current Ratio | 15.41 | 16.19 | 30.86 | 44.35 | 17.74 | |||
| Return On Assets (ROA) | -46.99% | -38.15% | -19.02% | -14.86% | -43.34% | |||
| Return On Equity (ROE) | -50.38% | -41.04% | -19.70% | -15.34% | -45.86% | |||
All data in USD